Skip to main content

2 Result(s)

within H. Seewann Remove this filter

and

  1. No Access

    Article

    Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

     In a prospective multicenter phase-II trial 80 patients with Philadelphia (Ph)-positive chronic myelogenous leukemia (CML) were treated with recombinant interferon (IFN)α-2c, administered subcutaneously at an...

    J. Thaler, G. Gastl, T. Fluckinger, D. Niederwieser, H. Huber… in Annals of Hematology (1996)

  2. No Access

    Chapter and Conference Paper

    Conversion of Myelodysplastic Subtypes to Acute Leukemia: A Follow-Up Study

    Primary myelodysplastic syndromes (MDS) are early phases of hematopoietic stem cell disorders [1, 5] occurring mainly in elderly people [2]. MDS are characterized by unexplained cytopenia(s), abnormalities of ...

    C. Schmid, R. Bartl, K. Jäger, A. Beham, H. Seewann… in Myelodysplastic Syndromes (1992)